Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.